NEWS
ОRIGINAL ARTICLES
The aim: to identify pathological characteristics of placenta in women with preterm labor according to the gestational age.
Materials and methods. The study involved 55 women who gave birth prematurely: 21 women with gestational age from |22 to 32 weeks (group 1) and 34 women with gestational age from 32 to 37 weeks (group 2). All the women had spontaneous singleton pregnancies followed by preterm spontaneous births. We conducted a comparative analysis of the social, clinical and amnestic information, as well as a histopathological study of the placentas; the latter included macroscopic description, organometry and microscopic morphology. The analysis aimed to identify the placental factors associated with the premature delivery occurred before and after 32 weeks of gestation.
Results. The study revealed a number of anamnestic and clinical factors associated with preterm births. At a gestational age up to 32 weeks, the placentas showed hypoplasia with a mass deficit of more than 30% in combination with proliferative vylusitis, post-inflammatory hypovascularization, abnormal differentiation of the vascular-stromal component of the villi, and insufficient compensatory and adaptive reactions. After 32 weeks of pregnancy the placenta characteristics included chronic disorders of the maternal and fetal blood circulation, compensatory hyperplasia of the terminal villi, capillaries and their syncytia capillary membranes.
Conclusion. There is a need for individual rehabilitation programs for women with the history of preterm births that would include their clinical and anamnestic background together with the pathomorphological characteristics of their placentas. Such a program is expected to help these women to be better prepared prior to their subsequent pregnancy.
Aim: to analyze the usefulness of laparoscopic methods for the recovery of reproductive health in women with polycystic ovary syndrome (PCOS).
Materials and methods. A continuous retrospective analysis of 56 outpatient cards and case histories of women with PCOS and concomitant infertility for the period from 2013 to 2015 was conducted using the documentation from the Kursk Regional Perinatal Center. The average age of the patients was 28.29 ± 4.43 years, the duration of infertility – from 1 to 15 years. Anamnestic and clinical data, concomitant pathology and long-term results of laparoscopic treatment and diagnostic procedures were studied.
Results. The patients underwent surgical treatment after conservative therapy failed to restore their fertility. As a result, 49 women (87.5%) were able to restore the regular menstrual cycle and 35 women (62.5%) got pregnant.
Conclusion. The use of laparoscopy revealed the ultimate cause of infertility and allowed for surgical treatment able to restore the reproductive women’s health.
To date, self administrations of recombinant human follicle-stimulating hormone (rhFSH) are carried out using pen injectors with minimal dose increments of 8.33 IU or 12.5 IU (IU – international units of activity). To ensure the accuracy of dose titration and to minimize the dose adjustments during the treatment, new pen injectors are needed. Those would provide for the self administration of rhFSH in a wide range of doses and with a dose increment less than the existing fractional values. Aim: to develop a pre-filled, multi-dose pen injector for rhFSH solution with a 5 IU dose increment and a dose setting from 0 to 300 IU.
Materials and methods. Dispensed volumes containing the minimal dose of 5 IU were measured gravimetrically.
Results. After testing 48 pen injectors the estimated minimal dose of 5 IU (0.0083 ml of the solution) produced the following results: the mean value of the dispensed volume was 0.0081 ml, the mean deviation was ± 0.0006 ml (or ± 0.36 IU). The results are in consistence with the ISO 11608-1:2014(E) requirements of dose accuracy for the minimal dose setting in commercial injectors.
Conclusion. We have developed a pen injector for rhFSH administration with a dose setting from 0 to 300 IU and with a minimal increment of dose adjustment of 5 IU. The individual approach to the dose selection/adjustment with a minimal increment of 5 IU may help achieving a highly accurate administration of rhFSH for the controlled ovarian hyperstimulation and for the induced-ovulation protocols with growth activation of 1-2 follicles.
The aim: to evaluate the astroglial neurospecific protein – gliofibrillary acidic protein (GFAP) in the blood serum of pregnant women with post-concussion syndrome (PCS) resulted from a mild closed brain injury. The serum level of GFAP was earlier proposed to be used as a marker of the state of the blood-brain barrier (BBB) and a predictor of obstetric and perinatal complications.
Materials and methods. To evaluate the permeability of the BBB and the integrity of astrocytes during pregnancy, we measured GFAP (using the enzyme immunoassay) in the sera of 93 women: 41 with PCS (main group), 31 somatically healthy pregnant women (comparison group), and 21 non-pregnant women of the reproductive age (control group).
Results. In healthy pregnant women, the level of GFAP did not significantly differ from that in the non-pregnant women and did not exceed a threshold value of 4.0 ng/ml. In most of the pregnant women with PCS (70.73%), the GFAP values exceeded the threshold level starting from the first trimester and tended to increase subsequently, which was indicative of immunological sensitization.
Conclusion. In the obstetric and neurological practice, pregnant women with PCS are recommend to be tested for their serum GFAP as a marker of immunological sensitization and a predictor of pregnancy and delivery complications as well as neurological deterioration.
REVIEW ARTICLE
CLINICAL CASE
REPORTAGES
FROM HISTORY

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
ISSN 2500-3194 (Online)